亿帆医药：目前还没有收到合作方对F627销售情况的反馈

Core Viewpoint - The company has not yet received feedback from its exclusive U.S. distributor regarding the sales performance of F627 in the third quarter [1] Group 1 - An investor inquired about the sales situation of F627 in the U.S. and whether it met or exceeded expectations [1] - The company expressed gratitude for the inquiry and confirmed the lack of feedback from its partner [1]